Linkage disequilibrium patterns and functional analysis of RGS4 polymorphisms in relation to schizophrenia

Schizophrenia Bulletin

Volumn 34, Issue 1, 2008, Pages 118-126

  Chowdari, Kodavali V ^a   Bamne, Mikhil ^a   Wood, Joel ^a   Talkowski, Michael E ^b   Mirnics, Karoly ^c   Levitt, Pat ^c   Lewis, David A ^a   Nimgaonkar, Vishwajit L ^a,b,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Association; Linkage disequilibrium; Promoter; RGS4; Schizophrenia

Indexed keywords

RGS4 PROTEIN;

ARTICLE; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FUNCTIONAL ASSESSMENT; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOMICS; HAPLOTYPE; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

EXONS; GENOTYPE; HAPLOTYPES; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; RGS PROTEINS; SCHIZOPHRENIA;

EID: 37149028110     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbm042     Document Type: Article

References (44)

1. De Vries L, Zheng B, Fischer T, Elenko E, Farquhar MG. The regulator of G protein signaling family. Annu Rev Pharmacol Toxicol. 2000;40:235-271.
2. Riddle EL, Schwartzman RA, Bond M, Insel PA. Multi-tasking RGS proteins in the heart: the next therapeutic target? Circ Res. 2005;96:401-411.
3. Ni YG, Gold SJ, Iredale PA, Terwilliger RZ, Duman RS, Nestler EJ. Region-specific regulation of RGS4 (regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies. J Neurosci. 1999;19:3674-3680.
4. Hepler JR. Emerging roles for RGS proteins in cell signalling. Trends Pharmacol Sci. 1999;20:376-382.
5. Kobori N, Clifton GL, Dash P. Altered expression of novel genes in the cerebral cortex following experimental brain injury. Brain Res Mol Brain Res. 2002;104:148-158.
6. Zachariou V, Georgescu D, Sanchez N, et al. Essential role for RGS9 in opiate action. Proc Natl Acad Sci USA. 2003;100:13656-13661.
7. Levitt P, Ebert P, Mirnics K, Nimgaonkar VL, Lewis DA. Making the case for a candidate vulnerability gene in schizophrenia: convergent evidence for regulator of G-protein signaling 4 (RGS4). Biol Psychiatry. 2006;60:534-537.
8. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry. 2001;6:293-301.
9. Erdely HA, Tamminga CA, Roberts RC, Vogel MW. Regional alterations in RGS4 protein in schizophrenia. Synapse. 2006;59:472-479.
10. Bowden NA, Scott RJ, Tooney PA. Altered expression of regulator of G-protein signalling 4 (RGS4) mRNA in the superior temporal gyrus in schizophrenia. Schizophr Res. 2007;89:165-168.
11. Lipska BK, Mitkus S, Caruso M, et al. RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity. Hum Mol Genet. 2006;15:2804-2812.
12. Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science. 2000;288:678-682.
13. Chowdari KV, Mirnics K, Semwal P, et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet. 2002;11:1373-1380.
14. Williams NM, Preece A, Spurlock G, et al. Support for RGS4 as a susceptibility gene for schizophrenia. Biol Psychiatry. 2004;55:192-195.
15. Morris DW, Rodgers A, McGhee KA, et al. Confirming RGS4 as a susceptibility gene for schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2004;125:50-53.
16. Chen X, Dunham C, Kendler S, et al. Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am J Med Genet B Neuropsychiatr Genet. 2004;129:23-26.
17. Bakker SC, Hoogendoorn MLC, Hendriks J, et al. The PIP5-K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behavior. 2007;6:113-119.
18. Fallin MD, Lasseter VK, Avramopoulos D, et al. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet. 2005;77:918-936.
19. Cordeiro Q, Talkowski ME, Chowdari KV, Wood J, Nimgaonkar V, Vallada H. Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil. Genes Brain Behav. 2005;4:45-50.
20. Zhang F, St Clair D, Liu X, et al. Association analysis of the RGS4 gene in Han Chinese and Scottish populations with schizophrenia. Genes Brain Behav. 2005;4:444-448.
21. Liu YL, Shen-Jang Fann C, Liu CM, et al. Evaluation of RGS4 as a candidate gene for schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2006;141:418-420.
22. Sobell JL, Richard C, Wirshing DA, Heston LL. Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians. Am J Med Genet B Neuropsychiatr Genet. 2005;139:23-27.
23. Rizig MA, McQuillin A, Puri V, et al. Failure to confirm genetic association between schizophrenia and markers on chromosome 1q23.3 in the region of the gene encoding the regulator of G-protein signaling 4 protein (RGS4). Am J Med Genet B Neuropsychiatr Genet. 2006;141:296-300.
24. Puri V, McQuillin A, Choudhury K, et al. Fine mapping by genetic association implicates the chromosome 1q23.3 gene UHMK1, encoding a serine/threonine protein kinase, as a novel schizophrenia susceptibility gene. Biol Psychiatry. 2007;61:873-879.
25. Ishiguro H, Horiuchi Y, Koga M, et al. RGS4 is not a susceptibility gene for schizophrenia in Japanese: association study in a large case-control population. Schizophr Res. 2007;89:161-164.
26. Talkowski ME, Seltman H, Bassett AS, et al. Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry. 2006;60:152-162.
27. Li D, He L. Association study of the G-protein signaling 4 (RGS4) and proline dehydrogenase (PRODH) genes with schizophrenia: a meta-analysis. Eur J Hum Genet. 2006;14:1130-1135.
28. Guo S, Tang W, Shi Y, et al. RGS4 polymorphisms and risk of schizophrenia: an association study in Han Chinese plus meta-analysis. Neurosci Lett. 2006;406:122-127.
29. Kwok PY. Approaches to allele frequency determination. Pharmacogenomics. 2000;1:231-235.
30. Chowdari KV, Northup A, Pless L, et al. DNA pooling: a comprehensive, multi-stage association analysis of ACSL6 and SIRT5 polymorphisms in schizophrenia. Genes Brain Behav. 2007;6:229-239.
31. Mansour HA, Wood J, Logue T, et al. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia.. Genes Brain Behav. 2006;5:150-157.
32. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet. 1998;63:259-266.
33. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265.
34. Rinaldo A, Bacanu SA, Devlin B, Sonpar V, Wasserman L, Roeder K. Characterization of multilocus linkage disequilibrium. Genet Epidemiol. 2005;28:193-206.
35. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet. 1996;58:1347-1363.
36. Chadha S, Miller K, Farwell L, et al. Haplotype structure of TNFRSF5-TNFSF5 (CD40-CD40L) and association analysis in systemic lupus erythematosus. Eur J Hum Genet. 2005;13:669-676.
37. Costas J, Salas A, Phillips C, Carracedo A. Human genome-wide screen of haplotype-like blocks of reduced diversity. Gene. 2005;349:219-225.
38. Shirts BH, Nimgaonkar V. The genes for schizophrenia: finally a breakthrough? Curr Psychiatry Rep. 2004;6:303-312.
39. Owen MJ, Craddock N, O'Donovan MC. Schizophrenia: genes at last? Trends Genet. 2005;21:518-525.
40. Bastian W. Genes with linkage or association with type 2 diabetes mellitus. J Pediatr Endocrinol Metab. 2002;15:Suppl 1471-484.
41. Nicodemus KK, Kolachana BS, Vakkalanka R, et al. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum Genet. 2007;120:889-906.
42. Winantea J, Hoang MN, Ohlraun S, et al. A summary statistic approach to sequence variation in noncoding regions of six schizophrenia-associated gene loci. Eur J Hum Genet. 2006;14:1037-1043.
43. Prasad KM, Chowdari KV, Nimgaonkar VL, Talkowski ME, Lewis DA, Keshavan MS. Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients. Mol Psychiatry. 2005;10:213-219.
44. Buckholtz JW, Meyer-Lindenberg A, Honea RA, et al. Allelic variation in RGS4 impacts functional and structural connectivity in the human brain. J Neurosci. 2007;27:1584-1593.